Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Purinostat mesylate | 2650188-32-0 | 99.5% | 586.62 | 5 MG
SDP

Catalog No. 5000361752
Encompass_Preferred

Purinostat mesylate is a selective inhibitor of HDAC, inhibiting class I and class IIb HDACs with IC50s ranging from 0.81 to 11.5 nM. It induces apoptosis and affects the cell cycle, demonstrating potent anti-leukemia effects in vivo. This product can be used for research on lymphoblastic leukemia.

  • Selective inhibitor of HDAC
  • Inhibits class I and class IIb HDACs
  • Induces apoptosis
  • Affects the cell cycle of LAMA84 and 188 BL-2 cells
  • Demonstrates potent anti-leukemia effects in vivo
  • Can be used for research on lymphoblastic leukemia

Catalog No. 50-003-61752 Supplier Medchemexpress LLC Supplier No. HY1501095MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Purinostat mesylate is a selective inhibitor of HDAC, inhibiting class I and class IIb HDACs with IC50s ranging from 0.81 to 11.5 nM. It induces apoptosis and affects the cell cycle, demonstrating potent anti-leukemia effects in vivo. This product can be used for research on lymphoblastic leukemia.

  • Selective inhibitor of HDAC
  • Inhibits class I and class IIb HDACs
  • Induces apoptosis
  • Affects the cell cycle of LAMA84 and 188 BL-2 cells
  • Demonstrates potent anti-leukemia effects in vivo
  • Can be used for research on lymphoblastic leukemia

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.